medigraphic.com
Anales de Otorrinolaringología Mexicana

2020, Number 3

<< Back Next >>

Otorrinolaringología 2020; 65 (3)

Injection of physiological solution as a predictor of success in the medialization of the vocal fold in patients with glottic insufficiency

Orozco-Sánchez A, Akaki-Caballero M

Language: Spanish
References: 17
Page: 130-136
PDF size: 219.21 Kb.


ABSTRACT

Background: Glottic insufficiency is defined as the incomplete closure of the vocal cords during phonation. There are two modalities in its treatment: surgery of the laryngeal skeleton and augmentation of the vocal fold with laryngeal injection; being safe and effective.
Objective: To report the use of injection of physiological solution as a predictor of success in the medialization of glottic insufficiency.
Material and Method: A clinical, descriptive, observational and retrospective study that reviewed all the records of patients treated at the Centro Medico Nacional 20 de Noviembre hospital, Mexico City, from May to October, 2019 with a diagnosis of glottic insufficiency conditioning dysphonia, treated by medialization injection with physiological solution and calcium hydroxyapatite and evaluated using the voice handicap index of 30 items and the maximum phonation time.
Results: Seventeen patients were identified; mostly women (82%) with a median age of 57 years; 77% had a history of neck surgery, total thyroidectomy was the most surgery performed (59%). Statistically significant improvement was obtained after the application of solution and medializer in the vocal disability index and decrease in maximum phonation time (p = 0.0003 and p = 0.0048).
Conclusions: Injection with physiological solution is a useful procedure in the prediction of a beneficial result in patients who require a semi-permanent material.


REFERENCES

  1. Dumberger LD, Overton L, Buckmire RA, Shah RN. Trial vocal fold injection predicts thyroplasty outcomes in nonparalytic glottic incompetence. Ann Otol Rhinol Laryngol 2017;126 (4): 279-83. https://doi. org/10.1177%2F0003489416688479

  2. Buckmire RA, Bryson PC, Patel MR. Type I gore-tex laryngoplasty for glottic incompetence in mobile vocal folds. J Voice 2011; 25 (3): 288-92. doi: 10.1016/j.jvoice.2009.12.003

  3. Pei YC, Fang TJ, Hsin LJ, Li HY, Wong AM. Early hyaluronate injection improves quality of life but not neural recovery in unilateral vocal fold paralysis: an open-label randomized controlled study. Restor Neurol Neurosci 2015; 33 (2): 121- 30. DOI: 10.3233/RNN-140439

  4. Lu F, Casiano RR, Lundy DS, Xue J. Vocal evaluation of thyroplasty type I in the treatment of non-paralytic glottic incompetence. Ann Otol Rhinol Laryngol 1998; 107: 113- 119. doi: 10.1177/000348949810700206

  5. Cantarella G, Dejonckere P, Galli A, Ciabatta A, Gaffuri M, Pignataro L, et al. A retrospective evaluation of the etiology of unilateral vocal fold paralysis over the last 25 years. Eur Arch Otorhinolaryngol 2017; 274 (1): 347-53. doi: 10.1007/ s00405-016-4225-9

  6. Rubin AD, Sataloff RT. Vocal fold paresis and paralysis. Otolaryngol Clin North Am 2007; 40 (5): 1109-31. doi: 10.1016/j.otc.2007.05.012

  7. King JM, Simpson CB. Modern injection augmentation for glottic insufficiency. Curr Opin Otolaryngol Head Neck Surg 2007; 15 (3): 153-8. doi: 10.1097/MOO.0b013e3281084e61

  8. Young VN, Smith LJ, Sulica L, Krishna P, Rosen CA. Patient tolerance of awake, in-office laryngeal procedures: A multi-institutional perspective. Laryngoscope 2012; 122 (2): 315-21. doi: 10.1002/lary.22185

  9. Sielska-Badurek EM, Sobol M, Jędra K, Rzepakowska A, Osuch-Wójcikiewicz E, Niemczyk K. Injection laryngoplasty as mini-invasive office-based surgery in patients with unilateral vocal fold paralysis-voice quality outcomes. Videosurgery Miniinv 2017; 3: 277-84. doi: 10.5114/wiitm.2017.68868

  10. Epstein EM, Waseem M. Crystalloid Fluids. [Updated 2020 Mar 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK537326/

  11. Richtsmeier WJ, Zeitels SM, Vaughan CW. A submucosal true vocal fold infusion needle. Otolaryngol Head Neck Surg 1991; 105 (3): 478-9. doi: 10.1177/019459989110500322

  12. Jacobson BH, Jonson A, Grywalski C, et al. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 1997; 6: 66-70. DOI :10.1044/1058- 0360.0603.66

  13. Wilson J, Webb A, Carding P, Steen I, MacKenzie K, Deary I. The Voice Symptom Scale (VoiSS) and the Vocal Handicap Index (VHI): a comparison of structure and content. Clin Otolaryngol. 2004; 29 (2): 169-74. doi: 10.1111/j.0307- 7772.2004.00775.x

  14. Núñez B, Corte S, Señaris GB, Llorente PJ, Górriz G, Suárez NC. Adaptación y validación del índice de incapacidad vocal (VHI-30) y su versión abreviada (VHI-10) al español. Acta Otorrinolaringol Esp 2007; 58 (9): 386-92. DOI: 10.1016/ S0001-6519(07)74954-3

  15. Zeleník K, Walderová R, Kučová H, Jančatová D, Komínek P. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection. Eur Arch Otorhinolaryngol 2017; 274 (8): 3147-51. doi: 10.1007/s00405-017-4600-1

  16. Granato F, Martelli F, Comini LV, Luparello P, Coscarelli S, Le Seac O, et al. The surgical treatment of unilateral vocal cord paralysis (UVCP): qualitative review analysis and metaanalysis study. Eur Arch Otorhinolaryngol 2019; 276 (10): 2649-59. doi: 10.1007/s00405-019-05587-2

  17. Lee M, Lee DY, Kwon T. Safety of office‐based percutaneous injection laryngoplasty with calcium hydroxylapatite. Laryngoscope 2019; 129 (10): 2361-5. https://doi.org/10.1002/lary.27861




2020     |     www.medigraphic.com